drugset / Trial / NCT00006656

Carmustine in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme

NCT00006656

Phase 2 Unknown Direct Therapeutics
Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of carmustine in treating patients who have progressive or recurrent glioblastoma multiforme.

Timeline

Start
2000-06
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject carmustine Small molecule Other